Financial Statements — NP
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 |
|---|
| Cash & Equivalents | 17.55 | 10.54 | 12.18 |
| Total Current Assets | 89.02 | 72.47 | 76.32 |
| Total Assets | 102.21 | 85.30 | 89.63 |
| Total Current Liabilities | 84.46 | 71.65 | 85.13 |
| Long-term Debt | -- | -- | 247.59 |
| Total Liabilities | 324.46 | 298.65 | 348.30 |
| Retained Earnings | (491.21) | (507.00) | (518.66) |
| Total Stockholder Equity | (222.24) | (213.36) | (509.55) |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 |
|---|
| Total Revenue | 55.87 | 37.80 | 43.77 | 44.37 |
| Operating Income | 26.55 | 13.44 | 13.34 | 20.70 |
| Tax Provision | 7.39 | 2.73 | 4.76 | 3.95 |
| Net Income | 15.80 | 7.35 | 4.34 | 11.51 |
| Diluted EPS | 0.11 | 0.05 | 0.08 | 0.06 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 |
|---|
| Operating Cash Flow | 26.71 | 16.69 | 12.75 | 38.92 |
| Investing Cash Flow | (1.07) | (1.10) | (1.05) | (2.93) |
| Financing Cash Flow | (8.99) | 4.25 | (30.20) | (5.01) |
